Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Keros Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Keros Therapeutics Inc. May 30, 202478.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Keros Therapeutics Inc. | Open-market sale | −2,625 | $10.73 | $28,166 |
| Jun 3, 2026 | Keros Therapeutics Inc. | Grant or award | +7,142 | — | — |
| Jun 4, 2025 | Keros Therapeutics Inc. | Grant or award | +5,250 | — | — |
Questions about Nima Farzan
What boards is Nima Farzan on?
Nima Farzan sits on the boards of Keros Therapeutics Inc. and Latigo Biotherapeutics Inc.
What company is Nima Farzan the CEO of?
Nima Farzan has been President and CEO of Latigo Biotherapeutics Inc. since August 2026.
How long has Nima Farzan served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.